Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-094009

Director sold 14,508 shares at $50.01 ($725,526)

  • Director acquired 14,508 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GOOD JENNIFER L · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-08-26 Exercise or conversion : show line 1 in the form 10b5-1 +2,100 $22.93 $48,153 5,100 D
2024-08-26 Exercise or conversion : show line 2 in the form 10b5-1 +4,945 $21.37 $105,675 10,045 D
2024-08-26 Exercise or conversion : show line 3 in the form 10b5-1 +5,763 $18.99 $109,439 15,808 D
2024-08-26 Exercise or conversion : show line 4 in the form 10b5-1 +1,700 $4.15 $7,055 17,508 D
2024-08-26 Sale : show line 5 in the form 10b5-1 −14,508 $50.01 $725,526 3,000 D
Open-market sales · 14,508 sh · avg $50.01 · $725,526

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-08-26 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −2,100 27,900 D
2024-08-26 Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) −4,945 13,555 D
2024-08-26 Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) −5,763 9,237 D
2024-08-26 Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) −1,700 18,300 D
Loading xslF345X05/tm2422915-1_4seq1.xml…